CL2015000889A1 - Compuestos derivados de [orto bi-(hetero-)aril]-[2-(meta bi-(hetero-)aril)-pirrolidin-1-il]-metanona, como antagonistas de receptores de orexina; composicion farmaceutica que los comprende; y su uso en la prevencion o tratamiento de enfermedades de la salud mental o trastornos relacionados con disfunciones orexinergicas. - Google Patents

Compuestos derivados de [orto bi-(hetero-)aril]-[2-(meta bi-(hetero-)aril)-pirrolidin-1-il]-metanona, como antagonistas de receptores de orexina; composicion farmaceutica que los comprende; y su uso en la prevencion o tratamiento de enfermedades de la salud mental o trastornos relacionados con disfunciones orexinergicas.

Info

Publication number
CL2015000889A1
CL2015000889A1 CL2015000889A CL2015000889A CL2015000889A1 CL 2015000889 A1 CL2015000889 A1 CL 2015000889A1 CL 2015000889 A CL2015000889 A CL 2015000889A CL 2015000889 A CL2015000889 A CL 2015000889A CL 2015000889 A1 CL2015000889 A1 CL 2015000889A1
Authority
CL
Chile
Prior art keywords
hetero
aryl
methanone
pyrrolidin
ortho
Prior art date
Application number
CL2015000889A
Other languages
English (en)
Inventor
Markus Gude
Christoph Boss
Christine Brotschi
Bibia Heidmann
Thierry Sifferlen
Martin Bolli
Jodi T Williams
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of CL2015000889A1 publication Critical patent/CL2015000889A1/es

Links

CL2015000889A 2012-10-10 2015-04-08 Compuestos derivados de [orto bi-(hetero-)aril]-[2-(meta bi-(hetero-)aril)-pirrolidin-1-il]-metanona, como antagonistas de receptores de orexina; composicion farmaceutica que los comprende; y su uso en la prevencion o tratamiento de enfermedades de la salud mental o trastornos relacionados con disfunciones orexinergicas. CL2015000889A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12880199 2012-10-10
EP13157809 2013-03-05

Publications (1)

Publication Number Publication Date
CL2015000889A1 true CL2015000889A1 (es) 2015-07-10

Family

ID=57232543

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2015000889A CL2015000889A1 (es) 2012-10-10 2015-04-08 Compuestos derivados de [orto bi-(hetero-)aril]-[2-(meta bi-(hetero-)aril)-pirrolidin-1-il]-metanona, como antagonistas de receptores de orexina; composicion farmaceutica que los comprende; y su uso en la prevencion o tratamiento de enfermedades de la salud mental o trastornos relacionados con disfunciones orexinergicas.

Country Status (1)

Country Link
CL (1) CL2015000889A1 (es)

Similar Documents

Publication Publication Date Title
LTPA2018511I1 (lt) Policikliniai karbamoilpiridino junginiai ir jų farmacinis panaudojimas
IL239355A0 (en) Compositions of gamma-hydroxybutyrate and their use in the treatment of disorders
HK1210030A1 (en) Sulfamoyl aryamides and the use thereof as medicaments for the treatment of hepatitis b
EP2827856A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MUSCLE DISEASES
IL214208A (en) Preserved heterotromatic bicycles, containing pharmaceutical preparations and their use in preventing the jak process
DK3444261T3 (da) 2,2-difluorpropionamidderivat af bardoxolonmethyl, farmaceutiske sammensætninger og polymorfer deraf til anvendelse ved behandling af visse lidelser
HK1207304A1 (en) Crhr1 antagonists for use in the treatment of patients having crh overactivity crh crhr1
DK2838539T3 (da) Østrogenderivater til anvendelse i behandlingen af neurologiske forstyrrelser
DK3040336T3 (da) Forbindelser til brug i behandling af TYK2 Kinase-medierede tilstande
HK1198909A1 (en) Compositions and methods for the treatment of hepatic diseases and disorders
HK1207860A1 (en) 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders 2--5---2h--3-
CL2014003325A1 (es) Compuestos derivados de difluoro-hexahidro-ciclopentaoxacinilos y difluoro-hexahidro-benzooxacinilos, inhibidores de bace 1; composicion farmaceutica; y su uso en el tratamiento de enfermedades con niveles elevados de beta-amiloide, tal como la enfermedad de alzheimer
HK1205467A1 (en) Pharmaceutical composition for the prophylaxis and treatment of psychological, behavioral and cognitive disorders
GB201511770D0 (en) Novel pharmaceutical formulationsand their use in the treatment of periodontal disease
HK1215794A1 (zh) 用於治療疾病的同種異體自噬體富集組合物
HK1197235A1 (zh) 二氫吡唑、其藥物組合物及其治療生育障礙的用途
GB2510659B (en) Synergistic combinations of alkylamine compounds and herbal sedatives for the treatment of e.g. insomnia, anxiety, depression, stress and/or distress
PT2859896T (pt) Composições farmacêuticas para o tratamento de distúrbios musculares
EP2897621A4 (en) COMPOUNDS AND COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES, PAIN AND FEVER, SKIN DISEASES, CANCER AND PRECULTURAL INJURIES
IL238461A0 (en) 1 hindole-3-carboxamide derivatives and their use as p2y12 inhibitors
IL234093A0 (en) Preparations and dosages for oral administration and their uses for the treatment of Gaucher's disease
EP2825183A4 (en) HERBAL COMPOSITION FOR THE TREATMENT OF METABOLISM DISEASES
CL2015000889A1 (es) Compuestos derivados de [orto bi-(hetero-)aril]-[2-(meta bi-(hetero-)aril)-pirrolidin-1-il]-metanona, como antagonistas de receptores de orexina; composicion farmaceutica que los comprende; y su uso en la prevencion o tratamiento de enfermedades de la salud mental o trastornos relacionados con disfunciones orexinergicas.
GB201207102D0 (en) CRHR1 antagonists for use in the treatment of patients having CRH overactivity
TH134234B (th) สารอนุพันธ์ไพราซีน (Pyrazine derivatives) และ การใช้ของสารนั้นในการบำบัด ของความผิกปกติทางประสาท